{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2Fpreclinical-testing-part-3-alzheimers-disease-june-2020-xRNzfsAM","width":444,"version":"1.0","type":"rich","title":"Preclinical Testing - Part 3: Alzheimer's Disease June 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/07725c26-15bb-4acb-97ae-83d59e2e3dd4/metabolism-mitochondria-oxidative-stress-inflammation.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/f8a75ad8-d4fe-4478-b6d2-de3d3db99556\" height=\"200\" width=\"100%\" title=\"Preclinical Testing - Part 3: Alzheimer&apos;s Disease June 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Having trouble keeping up with the literature in Alzheimer's Disease? We are here to help!\n\nIn this episode, Marcia covers papers published in June 2020 on treatment development done on animal models, targeting metabolism, mitochondria, oxidative stress, the gut microbiome, inflammatory pathways, glia, and autophagy. If you are interested in learning more about these pathological events, you should check out our episode on these disease mechanisms, covered by Anusha. We also have a number of episodes dedicated to pre-clinical testing, split by the intended target the cholinergic system, the glutamatergic system, synaptic function, tau, amyloid-beta, cognitive performance, and other multitargeted approaches. \n\nEnjoy!"}